Discovery of Novel MsbA Inhibitors with a Bivalent Molecular Generative Model

, which showed enhanced potency and lower plasma protein binding compared with cerastecin C. These findings demonstrate an effective AI-driven strategy for the development of next-generation MsbA inhibitors.